Coloplast Net Receivables vs Total Stockholder Equity Analysis

0QBO Stock

886.80 11.35 1.30%

Coloplast financial indicator trend analysis is way more than just evaluating Coloplast AS prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Coloplast AS is a good investment. Please check the relationship between Coloplast Net Receivables and its Total Stockholder Equity accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Coloplast AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Net Receivables vs Total Stockholder Equity

Net Receivables vs Total Stockholder Equity Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Coloplast AS Net Receivables account and Total Stockholder Equity. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Coloplast's Net Receivables and Total Stockholder Equity is 0.96. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Total Stockholder Equity in the same time period over historical financial statements of Coloplast AS, assuming nothing else is changed. The correlation between historical values of Coloplast's Net Receivables and Total Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of Coloplast AS are associated (or correlated) with its Total Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Stockholder Equity has no effect on the direction of Net Receivables i.e., Coloplast's Net Receivables and Total Stockholder Equity go up and down completely randomly.

Correlation Coefficient

0.96

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Net Receivables

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Most indicators from Coloplast's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Coloplast AS current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Coloplast AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Tax Provision is likely to drop to about 1.4 B in 2024. Selling General Administrative is likely to drop to about 6.1 B in 2024

	2019	2020	2023	2024 (projected)
Interest Income	360M	100M	115M	152.0M
Tax Provision	1.3B	1.4B	1.6B	1.4B

Interest Income Tax Provision

Coloplast fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Total Current Liabilities	Total Stockholder Equity	Retained Earnings	Other Assets	Cash And Short Term Investments	Net Receivables	Good Will	Short Term Investments	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Intangible Assets	Common Stock	Property Plant Equipment	Other Current Liab	Other Liab	Net Tangible Assets	Accounts Payable	Short Term Debt
Total Assets		0.93	0.92	0.98	0.97	0.94	0.83	0.95	0.84	-0.96	0.97	-0.69	-0.88	0.96	0.94	0.89	-0.42	0.95	0.9	0.83	-0.78	0.97	0.97
Short Long Term Debt Total	0.93		0.77	0.94	0.94	0.96	0.58	0.88	0.78	-0.94	0.91	-0.75	-0.9	0.85	0.83	0.75	-0.26	0.84	0.79	0.71	-0.66	0.87	0.88
Total Current Liabilities	0.92	0.77		0.83	0.83	0.77	0.85	0.9	0.65	-0.84	0.93	-0.42	-0.7	0.97	0.97	0.86	-0.38	0.99	0.94	0.84	-0.86	0.95	0.93
Total Stockholder Equity	0.98	0.94	0.83		1.0	0.98	0.77	0.96	0.92	-0.96	0.95	-0.83	-0.94	0.88	0.89	0.84	-0.44	0.89	0.88	0.82	-0.75	0.94	0.92
Retained Earnings	0.97	0.94	0.83	1.0		0.99	0.77	0.96	0.93	-0.97	0.96	-0.84	-0.95	0.88	0.89	0.86	-0.45	0.89	0.88	0.84	-0.77	0.95	0.93
Other Assets	0.94	0.96	0.77	0.98	0.99		0.67	0.95	0.9	-0.95	0.94	-0.87	-0.96	0.83	0.86	0.79	-0.35	0.85	0.86	0.79	-0.74	0.92	0.89
Cash And Short Term Investments	0.83	0.58	0.85	0.77	0.77	0.67		0.82	0.75	-0.72	0.78	-0.46	-0.63	0.85	0.84	0.82	-0.6	0.83	0.83	0.8	-0.73	0.86	0.8
Net Receivables	0.95	0.88	0.9	0.96	0.96	0.95	0.82		0.88	-0.91	0.99	-0.75	-0.89	0.89	0.96	0.83	-0.42	0.94	0.97	0.89	-0.87	0.98	0.91
Good Will	0.84	0.78	0.65	0.92	0.93	0.9	0.75	0.88		-0.84	0.83	-0.91	-0.89	0.69	0.75	0.75	-0.58	0.73	0.78	0.78	-0.68	0.83	0.76
Short Term Investments	-0.96	-0.94	-0.84	-0.96	-0.97	-0.95	-0.72	-0.91	-0.84		-0.93	0.76	0.95	-0.89	-0.87	-0.92	0.51	-0.89	-0.84	-0.86	0.8	-0.92	-0.93
Inventory	0.97	0.91	0.93	0.95	0.96	0.94	0.78	0.99	0.83	-0.93		-0.7	-0.88	0.92	0.98	0.84	-0.38	0.97	0.97	0.88	-0.87	0.99	0.94
Other Current Assets	-0.69	-0.75	-0.42	-0.83	-0.84	-0.87	-0.46	-0.75	-0.91	0.76	-0.7		0.91	-0.49	-0.55	-0.6	0.35	-0.53	-0.6	-0.62	0.53	-0.68	-0.63
Other Stockholder Equity	-0.88	-0.9	-0.7	-0.94	-0.95	-0.96	-0.63	-0.89	-0.89	0.95	-0.88	0.91		-0.75	-0.78	-0.85	0.46	-0.77	-0.79	-0.83	0.77	-0.87	-0.85
Total Liab	0.96	0.85	0.97	0.88	0.88	0.83	0.85	0.89	0.69	-0.89	0.92	-0.49	-0.75		0.94	0.88	-0.37	0.97	0.88	0.79	-0.76	0.94	0.97
Total Current Assets	0.94	0.83	0.97	0.89	0.89	0.86	0.84	0.96	0.75	-0.87	0.98	-0.55	-0.78	0.94		0.84	-0.41	0.98	0.99	0.89	-0.89	0.98	0.92
Intangible Assets	0.89	0.75	0.86	0.84	0.86	0.79	0.82	0.83	0.75	-0.92	0.84	-0.6	-0.85	0.88	0.84		-0.64	0.87	0.81	0.91	-0.86	0.89	0.91
Common Stock	-0.42	-0.26	-0.38	-0.44	-0.45	-0.35	-0.6	-0.42	-0.58	0.51	-0.38	0.35	0.46	-0.37	-0.41	-0.64		-0.42	-0.42	-0.7	0.57	-0.43	-0.34
Property Plant Equipment	0.95	0.84	0.99	0.89	0.89	0.85	0.83	0.94	0.73	-0.89	0.97	-0.53	-0.77	0.97	0.98	0.87	-0.42		0.96	0.88	-0.87	0.97	0.95
Other Current Liab	0.9	0.79	0.94	0.88	0.88	0.86	0.83	0.97	0.78	-0.84	0.97	-0.6	-0.79	0.88	0.99	0.81	-0.42	0.96		0.9	-0.92	0.97	0.88
Other Liab	0.83	0.71	0.84	0.82	0.84	0.79	0.8	0.89	0.78	-0.86	0.88	-0.62	-0.83	0.79	0.89	0.91	-0.7	0.88	0.9		-0.97	0.9	0.81
Net Tangible Assets	-0.78	-0.66	-0.86	-0.75	-0.77	-0.74	-0.73	-0.87	-0.68	0.8	-0.87	0.53	0.77	-0.76	-0.89	-0.86	0.57	-0.87	-0.92	-0.97		-0.88	-0.79
Accounts Payable	0.97	0.87	0.95	0.94	0.95	0.92	0.86	0.98	0.83	-0.92	0.99	-0.68	-0.87	0.94	0.98	0.89	-0.43	0.97	0.97	0.9	-0.88		0.96
Short Term Debt	0.97	0.88	0.93	0.92	0.93	0.89	0.8	0.91	0.76	-0.93	0.94	-0.63	-0.85	0.97	0.92	0.91	-0.34	0.95	0.88	0.81	-0.79	0.96

Click cells to compare fundamentals

Coloplast Account Relationship Matchups

Coloplast fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	11.8B	12.7B	13.5B	15.8B	18.2B	14.5B
Short Long Term Debt Total	91M	134M	430M	449M	516.4M	264.4M
Total Current Liabilities	4.9B	5.0B	6.3B	7.3B	8.4B	6.2B
Total Stockholder Equity	6.4B	6.9B	7.4B	8.2B	9.4B	7.7B
Retained Earnings	6.9B	7.5B	8.4B	8.6B	9.9B	8.0B
Other Assets	1.1B	1.5B	1.7B	1.9B	2.2B	1.4B
Cash And Short Term Investments	607M	669M	585M	674M	775.1M	696.1M
Net Receivables	3.6B	3.5B	3.7B	4.7B	5.4B	3.9B
Good Will	2.0B	2.0B	2.0B	2.0B	2.3B	2.1B
Short Term Investments	310M	313M	262M	226M	203.4M	228.2M
Inventory	1.9B	2.2B	2.4B	3.2B	3.7B	2.4B
Other Stockholder Equity	(228M)	(315M)	(433M)	(495M)	(445.5M)	(467.8M)
Total Liab	5.4B	5.8B	6.1B	7.7B	8.8B	6.8B
Total Current Assets	6.4B	6.5B	7.0B	8.8B	10.1B	7.4B
Intangible Assets	534M	472M	388M	1.6B	1.9B	2.0B
Property Plant Equipment	2.8B	3.2B	3.6B	4.1B	4.8B	3.6B
Other Current Liab	3B	2.8B	2.9B	4.2B	4.9B	3.4B
Other Liab	743M	684M	910M	2.5B	2.8B	3.0B
Net Tangible Assets	4.5B	5.1B	4.6B	(11.8B)	(10.6B)	(10.1B)
Accounts Payable	859M	814M	1.0B	1.2B	1.4B	1.0B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Coloplast Stock Analysis

When running Coloplast's price analysis, check to measure Coloplast's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coloplast is operating at the current time. Most of Coloplast's value examination focuses on studying past and present price action to predict the probability of Coloplast's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coloplast's price. Additionally, you may evaluate how the addition of Coloplast to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Coloplast Net Receivables vs Total Stockholder Equity Analysis

Net Receivables vs Total Stockholder Equity

Net Receivables vs Total Stockholder Equity Correlation Analysis

Correlation Coefficient

Net Receivables

Total Stockholder Equity

Coloplast fundamental ratios Correlations

Coloplast Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Coloplast fundamental ratios Accounts

Also Currently Popular

Additional Tools for Coloplast Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Retained Earnings	+ 1.0	Total Stockholder Equity
Property Plant Equipment	+ 0.99	Total Current Liabilities
Other Assets	+ 0.99	Retained Earnings
Inventory	+ 0.99	Net Receivables
Accounts Payable	+ 0.99	Inventory
Other Current Liab	+ 0.99	Total Current Assets

Net Tangible Assets	- 0.97	Other Liab
Short Term Investments	- 0.97	Retained Earnings
Other Stockholder Equity	- 0.96	Other Assets
Short Term Investments	- 0.96	Total Stockholder Equity
Short Term Investments	- 0.96	Total Assets
Short Term Investments	- 0.95	Other Assets